Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chiesi Ventures
Boston, Massachusetts, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Chiesi Ventures is an active venture capital firm, not a therapeutic development company itself, but backs early-stage biotechs primarily targeting rare and orphan diseases[3][7].
- Therapeutic areas
- OncologyNeurologyMetabolic DisordersRare Diseases
- Modalities
- Gene therapyMonoclonal antibodyAntibody-drug conjugateSmall moleculeCell therapyViral-like nanoparticle
- Industry
- Investors
02
Partnerships
Universities (various in US/EU)Venture investorsRare disease patient organizationsEntrepreneurial biotechs developing rare disease therapies
Beyond the preview
Go deeper on Chiesi Ventures.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chiesi Ventures.